Literature DB >> 8606096

Susceptibility of lipopolysaccharide-responsive and -hyporesponsive ItyS Mice to infection with rough mutants of Salmonella typhimurium.

I Mattsby-Baltzer1, B Ahlström, L Edebo, P de Man.   

Abstract

The R5 (chemotype Rb) but not the R10 (chemotype Rd) mutant of murine pathogen Salmonella typhimurium 395MS was extremely virulent in intraperitoneal infections of C57BL/10ScCr mice carrying the ityS and lpsD alleles. C57BL/6J (ityS lpsN) and C3H/HeJ (ityR lpsD) mice showed a much higher resistance to the R5 mutant. Further studies were performed with peritoneal macrophages in vitro in order to elucidate susceptibility in lipopolysaccharide (LPS)-hyporesponsive mice carrying ItyS. The intracellular killing capacity of the ItyS LpsD macrophages was lower than that of the ItyS LpsN macrophages for the R5 mutant and may partly explain the increased susceptibility of the ItyS LpsD mice. The deep rough mutant, R10, was rapidly killed intracellularly by the ItyS LpsD macrophages. Processing of the bacteria in macrophages that had phagocytosed R5 or R10 bacteria was followed for up to 18 days by endotoxin measurements (limulus assay) and immunostaining, with monoclonal antibodies to various parts of the LPS molecule being used. Only 0.1% or less of the macrophage-associated bacteria remained alive after 48 h of incubation, and none were alive on day 7. Although immunostaining showed that LPS was present in both the LpsD and LpsN macrophages during the whole incubation period of 18 days, endotoxin activity in the LpsD macrophages on day 7 was lower than that in the LpsN macrophages, indicating that qualitative modifications of the chemical composition or physical state of the LPS molecule occurred. The interleukin-6 response in the ItyS LpsD macrophages was delayed and of shorter duration compared with that in the ItyS LpsN macrophages. The results suggest that the difference between the LPS-hyporesponsive and -responsive ItyS mice in susceptibility to infection with the R5 mutant was due to the lower activation state of the LpsD macrophages during infection, leading to a lower intracellular bactericidal systems of the macrophages. A rapid killing of the bacterium should restrict the infection and may partly compensate for a diminished inflammatory response. The persistence of LPS within the cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606096      PMCID: PMC173921          DOI: 10.1128/iai.64.4.1321-1327.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  How do animal phagocytes process bacterial lipopolysaccharides?

Authors:  R S Munford
Journal:  APMIS       Date:  1991-06       Impact factor: 3.205

2.  Role of cell wall structure of salmonella in the interaction with phagocytes.

Authors:  D Friedberg; M Shilo
Journal:  Infect Immun       Date:  1970-09       Impact factor: 3.441

3.  Independence of macrophage activation and expression of the alleles of the Ity (immunity to typhimurium) locus.

Authors:  D E Briles; W Benjamin; B Posey; S M Michalek; J R McGhee
Journal:  Microb Pathog       Date:  1986-02       Impact factor: 3.738

4.  Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene.

Authors:  A D O'Brien; D L Rosenstreich; I Scher; G H Campbell; R P MacDermott; S B Formal
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

5.  Genetic control of lipopolysaccharide induced generation of serum colony stimulating factor and proliferation of splenic granulocyte/macrophage precursor cells.

Authors:  R N Apte; D H Pluznik
Journal:  J Cell Physiol       Date:  1976-10       Impact factor: 6.384

6.  Dissociation of innate susceptibility to Salmonella infection and endotoxin responsiveness in C3HeB/FeJ mice and other strains in the C3H lineage.

Authors:  T K Eisenstein; L W Deakins; L Killar; P H Saluk; B M Sultzer
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

7.  Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg.

Authors:  S M Vidal; D Malo; K Vogan; E Skamene; P Gros
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

8.  Defective tumoricidal capacity of macrophages from C3H/HeJ mice.

Authors:  L P Ruco; M S Meltzer
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

9.  Retention of bacterial lipopolysaccharide at the site of subcutaneous injection.

Authors:  T Yokochi; Y Inoue; J Yokoo; Y Kimura; N Kato
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

10.  Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro.

Authors:  C R Lissner; R N Swanson; A D O'Brien
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

View more
  3 in total

1.  The polysaccharide portion of lipopolysaccharide regulates antigen-specific T-cell activation via effects on macrophage-mediated antigen processing.

Authors:  N M Zirk; S F Hashmi; H K Ziegler
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  17Beta-estradiol downregulates Kupffer cell TLR4-dependent p38 MAPK pathway and normalizes inflammatory cytokine production following trauma-hemorrhage.

Authors:  Ya-Ching Hsieh; Michael Frink; Bjoern M Thobe; Jun-Te Hsu; Mashkoor A Choudhry; Martin G Schwacha; Kirby I Bland; Irshad H Chaudry
Journal:  Mol Immunol       Date:  2006-12-19       Impact factor: 4.407

3.  Yersinia pestis Interacts With SIGNR1 (CD209b) for Promoting Host Dissemination and Infection.

Authors:  Kun Yang; Yingxia He; Chae Gyu Park; Young Sun Kang; Pei Zhang; Yanping Han; Yujun Cui; Silvia Bulgheresi; Andrey P Anisimov; Svetlana V Dentovskaya; Xiaoling Ying; Lingyu Jiang; Honghui Ding; Olivia Adhiambo Njiri; Shusheng Zhang; Guoxing Zheng; Lianxu Xia; Biao Kan; Xin Wang; Huaiqi Jing; Meiying Yan; Wei Li; Yuanzhi Wang; Xiding Xiamu; Gang Chen; Ding Ma; Sara Schesser Bartra; Gregory V Plano; John D Klena; Ruifu Yang; Mikael Skurnik; Tie Chen
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.